NYSE:MLSS Milestone Scientific (MLSS) Stock Price, News & Analysis $0.92 -0.03 (-3.35%) As of 02:26 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsTrendsBuy This Stock About Milestone Scientific Stock (NYSE:MLSS) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get Milestone Scientific alerts:Sign Up Key Stats Today's Range$0.91▼$0.9950-Day Range$0.87▼$1.0952-Week Range$0.58▼$1.39Volume29,769 shsAverage Volume128,171 shsMarket Capitalization$72.43 millionP/E RatioN/ADividend YieldN/APrice Target$1.25Consensus RatingBuy Company OverviewMilestone Scientific Inc., a biomedical technology research and development company, patents, designs, develops, and commercializes diagnostic and therapeutic injection technologies, and devices for medical, dental, and cosmetic use in the United States, China, and internationally. The company operates through Dental and Medical segments. Its products include CompuDent and STA Single Tooth Anesthesia System that are used for all dental procedures that require local anesthetic. In addition, the company offers CompuFlo, a computer-controlled drug delivery system for the painless delivery of drugs, anesthetics, and other medicaments, as well as for the aspiration of bodily fluids or previously injected substances, and disposable injection handpiece for the tactile control during the injection. Further, it provides CompuFlo Epidural, a computer-controlled anesthesia system for use in various medical applications. Additionally, the company offers company offers CompuMed for use in various medical procedures performed in plastic, hair restoration, and colorectal surgery, as well as podiatry, dermatology, orthopedics, and various other disciplines. Milestone Scientific Inc. was incorporated in 1989 and is headquartered in Roseland, New Jersey.Read More… Receive MLSS Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Milestone Scientific and its competitors with MarketBeat's FREE daily newsletter. Email Address MLSS Stock News HeadlinesMilestone Scientific Appoints Highly Accomplished MedTech Executive Shanth Thiyagalingam to Board of DirectorsMay 19, 2025 | globenewswire.comMilestone Scientific, Inc.: Milestone Scientific Reports Revenue of $2.2 Million and Provides Business Update for the First Quarter of 2025May 17, 2025 | finanznachrichten.deSocial Security Could Change Forever — Here's What I KnowWhen we say the way income could be calculated for Social Security is about to change forever — we don't make that claim lightly. These institutions pay us top dollar because we track exactly how big federal changes like this could send ripples through the stock market. And right now, we are sounding the alarm.May 30, 2025 | Altimetry (Ad)Milestone Scientific Reports Revenue of $2.2 Million and Provides Business Update for the First Quarter of 2025May 15, 2025 | globenewswire.comMilestone Scientific Reports Year-End 2024 Financial Results and Reports Strong Outlook for 2025April 15, 2025 | markets.businessinsider.comMilestone Scientific expands CompuFlo Epidural System footprint with InfiniSurgApril 2, 2025 | finance.yahoo.comMilestone Scientific Expands CompuFlo® Epidural System Footprint with InfiniSurg, LLC in New JerseyApril 1, 2025 | globenewswire.comMilestone Scientific announces CompuFlo rollout at Pain Doctors MedicalFebruary 4, 2025 | markets.businessinsider.comSee More Headlines MLSS Stock Analysis - Frequently Asked Questions How have MLSS shares performed this year? Milestone Scientific's stock was trading at $0.96 at the beginning of 2025. Since then, MLSS shares have decreased by 3.6% and is now trading at $0.9250. View the best growth stocks for 2025 here. How were Milestone Scientific's earnings last quarter? Milestone Scientific Inc. (NYSE:MLSS) released its quarterly earnings results on Thursday, August, 15th. The company reported ($0.02) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.01) by $0.01. The firm earned $1.85 million during the quarter. Milestone Scientific had a negative trailing twelve-month return on equity of 60.26% and a negative net margin of 52.01%. Who are Milestone Scientific's major shareholders? Milestone Scientific's top institutional investors include Brookwood Investment Group LLC (0.06%) and XTX Topco Ltd (0.04%). Insiders that own company stock include Leonard Osser, Neal I Goldman, Michael Mcgeehan and Leslie Bernhard. View institutional ownership trends. How do I buy shares of Milestone Scientific? Shares of MLSS stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of Milestone Scientific own? Based on aggregate information from My MarketBeat watchlists, some other companies that Milestone Scientific investors own include Waste Connections (WCN), DiamondRock Hospitality (DRH), The RMR Group (RMR), AUO (AUOTY), iShares Micro-Cap ETF (IWC), American Water Works (AWK) and Triple Flag Precious Metals (TFPM). Company Calendar Last Earnings8/15/2024Today5/30/2025Fiscal Year End12/31/2025Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNYSE SectorMedical Industry Surgical appliances & supplies Sub-IndustryMedical Equipment Current SymbolNYSE:MLSS CIK855683 Webwww.milestonescientific.com Phone(973) 535-2717Fax973-535-2829Employees30Year FoundedN/APrice Target and Rating Average Stock Price Target$1.25 High Stock Price Target$1.25 Low Stock Price Target$1.25 Potential Upside/Downside+30.2%Consensus RatingBuy Rating Score (0-4)3.00 Research Coverage1 Analysts Profitability EPS (Most Recent Fiscal Year)($0.07) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income-$6.93 million Net Margins-52.01% Pretax Margin-52.21% Return on Equity-60.26% Return on Assets-40.23% Debt Debt-to-Equity RatioN/A Current Ratio2.85 Quick Ratio1.86 Sales & Book Value Annual Sales$8.61 million Price / Sales8.75 Cash FlowN/A Price / Cash FlowN/A Book Value$0.11 per share Price / Book8.73Miscellaneous Outstanding Shares78,477,000Free Float58,614,000Market Cap$75.34 million OptionableOptionable Beta0.93 A Beginner's Guide to Investing in CannabisUnlock your free copy of MarketBeat's comprehensive guide to pot stock investing and discover which cannabis companies are poised for growth. Plus, you'll get exclusive access to our daily newsletter with expert stock recommendations from Wall Street's top analysts.Get This Free Report This page (NYSE:MLSS) was last updated on 5/30/2025 by MarketBeat.com Staff From Our PartnersCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredTrump Just Gave the Green Light to Rewrite Social Security?In a stunning move, President Trump has authorized an AI-led transformation of federal agencies, including Soc...Altimetry | SponsoredNow I look stupid. Real stupid... I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | SponsoredBuffett’s Next Move Could Shock Wall StreetIn just a few weeks, a move decades in the making could be revealed — and when it is, it could ignite the next...Golden Portfolio | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredThe Robotics Revolution has arrived … and one $7 stock could take off as a result.Robots aren't coming to America in 2025. They are already here. Oxford Economics says, "The Robotics Rev...Weiss Ratings | SponsoredWe’ve Entered the Most Bullish Phase of the CycleIt happens like clockwork. Every four years, the crypto market enters a new phase — and for those who know how...Crypto Swap Profits | Sponsored3..2..1.. AI 2.0 ignition (don’t sleep on this)I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Milestone Scientific Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Milestone Scientific With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.